| PHUSE collaborations are organised into a number of specialist Working Groups, each with a broad topic area. The Working Groups have specific projects designed to achieve a set of particular objectives. This page will highlight the latest news and information from our projects. Participation is open to anyone who wants to contribute and if you would like to get involved, please email workinggroups@phuse.global. |
| Working Group Quarterly Report |
|---|
We have just wrapped up the last Working Group Report for 2024! You can now view the Quarter 4 summary here, where you can see each of the project reports and some of the highlights across our Working Groups for this final quarter. Don’t forget to check out our Working Group Events Report too, where you will see a breakdown of some of the data collected from our Working Group Events for 2024. Well done to all our Working Groups who have a fantastic 2024! |
| Announcement - Emerging Trends and Technology Working Group Is Changing It's Name to Emerging Trends and Innovation |
|---|
The "Emerging Trends and Technology" (ET&T) Working Group is changing its name! This Working Group will now be called "Emerging Trends and Innovation" (ET&I). Hear from one of the Working Group's Leads, Mike Hamidi, on why they are making this change: "The proposed name change from Emerging Trends & Technologies to Emerging Trends & Innovations reflects a broader focus beyond just technological enablement. This shift encompasses not only ongoing developments in areas such as AI/ML, digital health technologies, and healthcare standards but also aims to provide deeper insights into these and other evolving topics. We believe this adjustment will preserve the emphasis on emerging trends while enhancing our commitment to delivering valuable industry innovations." |
| Announcement - PHUSE/FDA CSS 2025 |
|---|
In its 14th year, the PHUSE/FDA Computational Science Symposium (CSS) will be expanding its global reach! In addition to Silver Spring, Maryland, we will be running a simultaneous event in Utrecht, the Netherlands! Mark Your Calendars! The US event will be in Silver Spring, Maryland 19-21 May, and the EU event will be in Utrecht, the Netherlands 20-21 May. Please visit the PHUSE website for more information. |
| Data Transparency Winter Event 2025 |
Call for Speakers has closed for the Data Transparency Winter Event 2025! Taking place virtually 4-6 February, this event presents an incredible opportunity to showcase your ideas, share insight and engage with a vibrant community dedicated to advancing data transparency in the industry. Abstracts are currently being reviewed and the agenda drafted, watch this space for exciting agenda announcement's coming soon! |
The Analyses & Displays for Hepatotoxicity project within the Safety Analytics Working Group has produced a white paper, ‘Recommendations for Analyses and Displays Associated with Hepatotoxicity with a Focus on Phase 2-4 Clinical Trials and Integrated Submission Documents Stage 1: Initial Assessment and Screening for Potential for Hepatotoxicity'. The purpose of this document is to provide recommendations for displaying, summarising, and analysing measures of hepatotoxicity in tables, figures, and listings (TFLs). The suggested TFLs will have implications for what and how liver-related data should be collected. Please provide your comments by emailing workinggroups@phuse.global. Closing date for comments: 20 December |
| The AE Groupings in Safety (AEGiS) project within the Safety Analytics Working Group has published a new white paper. This white paper outlines why using standard AE groupings for queries is key to understanding a drug’s safety profile, discusses assumptions underlying the use of standard queries for estimation and outlines the benefits of standard queries when available. When standard queries are not available, but detailed analysis of a specific medical condition is needed, this document recommends a process to develop and maintain a custom query that can be replicated by regulatory authorities. |
The SDTM ADaM Implementation FAQ project within the Optimizing the Use of Data Standards Working Group has published a new FAQ! They have answered a FAQ with SDTM/ADaM IG Nuances, which is about the Use of Different Versions of MedDRA SMQs and CMQs for a Single Study. You can view this question and see the FAQ's this project has answered so far via here. Do you have a SDTM ADaM Implementation FAQ question? You can send your questions to the team by emailing workinggroups@phuse.global. |
If you would like to get involved in a PHUSE Working Group Project, please explore the projects via the Working Group Tabs and contact the PHUSE Office on workinggroups@phuse.global to express your interest. |
Working Groups Report: Includes project updates, recent and upcoming deliverables and future plans for each Working Group. | |
Monthly Mailings: The monthly newsletter. Here you will find a full update from each month of the year, easily accessible and divided into key areas of PHUSE. | |
PHUSE Blogs: Fancy a quick read? A blog is a perfect way to catch up on all things Working Groups. Get the lowdown on the latest events from across the globe and stay updated on industry topics brought to you by industry professionals. |
Initiate and lead a new project under the PHUSE Working Groups umbrella. The new project must address problems of significant relevance to computational science related to drug, biological and device development and must meet all of the guidelines for projects within the collaboration, including the following mandatory requirements:
New projects can be submitted anytime during the year, click here to submit. |